Matches in SemOpenAlex for { <https://semopenalex.org/work/W2962847486> ?p ?o ?g. }
- W2962847486 endingPage "1015" @default.
- W2962847486 startingPage "1015" @default.
- W2962847486 abstract "Epithelioid sarcoma (ES) is a rare mesenchymal malignancy marked by SMARCB1/INI1 deficiency. Retrospective clinical data report on the activity of anthracycline- and gemcitabine-based regimens. EZH2 inhibitors are currently being tested in clinical trials. Since comparisons of these agents are unlikely to be prospectively evaluated in the clinics, we took advantage of an INI1-deficient proximal-type ES patient-derived xenograft (PDX ES-1) to comparatively assess its preclinical antitumor activity. Mice were treated with doxorubicin and ifosfamide, singly or in combination, gemcitabine, and the EZH2 inhibitor EPZ-011989. Comparable antitumor activity (max tumor volume inhibition: ~90%) was caused by gemcitabine, EPZ-011989, and the doxorubicin–ifosfamide combination. The integration of RNAseq data, generated on tumors obtained from untreated and EPZ-011989-treated mice, and results from functional studies, carried out on the PDX-derived ES-1 cell line, revealed autophagy induction as a possible survival mechanism in residual tumor cells following EPZ-011989 treatment and identified HMGA2 as a main player in this process. Our data support the clinical use of gemcitabine and the doxorubicin–ifosfamide combination, confirm EZH2 as a therapeutic target in proximal-type ES, and suggest autophagy as a cytoprotective mechanism against EZH2 inhibition." @default.
- W2962847486 created "2019-07-30" @default.
- W2962847486 creator A5010089612 @default.
- W2962847486 creator A5024463077 @default.
- W2962847486 creator A5029415642 @default.
- W2962847486 creator A5030514699 @default.
- W2962847486 creator A5031501945 @default.
- W2962847486 creator A5034595315 @default.
- W2962847486 creator A5036195733 @default.
- W2962847486 creator A5040210154 @default.
- W2962847486 creator A5041886681 @default.
- W2962847486 creator A5053190653 @default.
- W2962847486 creator A5060954086 @default.
- W2962847486 creator A5061442888 @default.
- W2962847486 creator A5064244896 @default.
- W2962847486 creator A5064897676 @default.
- W2962847486 creator A5066380305 @default.
- W2962847486 creator A5071309513 @default.
- W2962847486 creator A5071715614 @default.
- W2962847486 creator A5072486452 @default.
- W2962847486 creator A5087564490 @default.
- W2962847486 creator A5087760720 @default.
- W2962847486 creator A5089343179 @default.
- W2962847486 date "2019-07-19" @default.
- W2962847486 modified "2023-10-18" @default.
- W2962847486 title "Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived Xenograft" @default.
- W2962847486 cites W1775295192 @default.
- W2962847486 cites W1873710893 @default.
- W2962847486 cites W1966980951 @default.
- W2962847486 cites W1983161785 @default.
- W2962847486 cites W1988051451 @default.
- W2962847486 cites W2005067491 @default.
- W2962847486 cites W2011115717 @default.
- W2962847486 cites W2028257398 @default.
- W2962847486 cites W2028818304 @default.
- W2962847486 cites W2029921580 @default.
- W2962847486 cites W2032424314 @default.
- W2962847486 cites W2036230897 @default.
- W2962847486 cites W2048637158 @default.
- W2962847486 cites W2056094896 @default.
- W2962847486 cites W2064494688 @default.
- W2962847486 cites W2079879959 @default.
- W2962847486 cites W2086652499 @default.
- W2962847486 cites W2087640406 @default.
- W2962847486 cites W2087796788 @default.
- W2962847486 cites W2094139498 @default.
- W2962847486 cites W2098738823 @default.
- W2962847486 cites W2103757717 @default.
- W2962847486 cites W2114104545 @default.
- W2962847486 cites W2130410032 @default.
- W2962847486 cites W2155100666 @default.
- W2962847486 cites W2165999779 @default.
- W2962847486 cites W2229833364 @default.
- W2962847486 cites W2264682687 @default.
- W2962847486 cites W2313149101 @default.
- W2962847486 cites W2400261832 @default.
- W2962847486 cites W2529083585 @default.
- W2962847486 cites W2543870678 @default.
- W2962847486 cites W2587201730 @default.
- W2962847486 cites W2592379645 @default.
- W2962847486 cites W2594271690 @default.
- W2962847486 cites W2616864589 @default.
- W2962847486 cites W2747620054 @default.
- W2962847486 cites W2752326209 @default.
- W2962847486 cites W2781829428 @default.
- W2962847486 cites W2792618749 @default.
- W2962847486 cites W2797262577 @default.
- W2962847486 cites W2797292560 @default.
- W2962847486 cites W2808497725 @default.
- W2962847486 cites W2898578088 @default.
- W2962847486 cites W2902084106 @default.
- W2962847486 cites W2970021941 @default.
- W2962847486 doi "https://doi.org/10.3390/cancers11071015" @default.
- W2962847486 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6678245" @default.
- W2962847486 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31331120" @default.
- W2962847486 hasPublicationYear "2019" @default.
- W2962847486 type Work @default.
- W2962847486 sameAs 2962847486 @default.
- W2962847486 citedByCount "19" @default.
- W2962847486 countsByYear W29628474862020 @default.
- W2962847486 countsByYear W29628474862021 @default.
- W2962847486 countsByYear W29628474862022 @default.
- W2962847486 countsByYear W29628474862023 @default.
- W2962847486 crossrefType "journal-article" @default.
- W2962847486 hasAuthorship W2962847486A5010089612 @default.
- W2962847486 hasAuthorship W2962847486A5024463077 @default.
- W2962847486 hasAuthorship W2962847486A5029415642 @default.
- W2962847486 hasAuthorship W2962847486A5030514699 @default.
- W2962847486 hasAuthorship W2962847486A5031501945 @default.
- W2962847486 hasAuthorship W2962847486A5034595315 @default.
- W2962847486 hasAuthorship W2962847486A5036195733 @default.
- W2962847486 hasAuthorship W2962847486A5040210154 @default.
- W2962847486 hasAuthorship W2962847486A5041886681 @default.
- W2962847486 hasAuthorship W2962847486A5053190653 @default.
- W2962847486 hasAuthorship W2962847486A5060954086 @default.
- W2962847486 hasAuthorship W2962847486A5061442888 @default.
- W2962847486 hasAuthorship W2962847486A5064244896 @default.
- W2962847486 hasAuthorship W2962847486A5064897676 @default.